Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Spielman

Showing results (41-50 of 69) with videos related to

Pageof 7
Sort By:
Chest|May 1, 1979
Electrophysiologic study of the left ventricle: indications and safetyE L Michelson, S R Spielman, A M Greenspan, et al.
Circulation|March 1, 1979
Recurrent sustained ventricular tachycardia. 4. PleomorphismM E Josephson, L N Horowitz, A Farshidi, et al.
Clinical Pharmacology and Therapeutics|June 1, 1985
Conversion from intravenous to oral mexiletine in the acute management of repetitive ventricular arrhythmiaL N Horowitz, A M Greenspan, S R Spielman, et al.
Journal of the American College of Cardiology|July 1, 1987
Reduction in sudden death and total mortality by antiarrhythmic therapy evaluated by electrophysiologic drug testing: criteria of efficacy in patients with sustained ventricular tachyarrhythmiaT J Waller, H R Kay, S R Spielman, et al.
The American Journal of Cardiology|May 1, 1988
Relation of acute antiarrhythmic drug efficacy to left ventricular function in coronary artery diseaseM D Meissner, H R Kay, L N Horowitz, et al.
Journal of the American College of Cardiology|August 1, 1985
Limitations of failure of procainamide during electrophysiologic testing to predict response to other medical therapyA P Rae, N M Sokoloff, C R Webb, et al.
Archives of Internal Medicine|October 1, 1982
Intravenous nitroglycerin for rest angina. Potential pathophysiologic mechanisms of actionN L DePace, I M Herling, M N Kotler, et al.
The American Journal of Cardiology|August 1, 1985
Efficacy of combination therapy with mexiletine and a type IA agent for inducible ventricular tachyarrhythmias secondary to coronary artery diseaseA M Greenspan, S R Spielman, C R Webb, et al.
The American Journal of Cardiology|August 1, 1987
Determinants of hospital cost and length of stay for patients undergoing electrophysiologic testingH R Kay, L N Horowitz, H Goldstein, et al.
Genomics|November 1, 1993
A microsatellite-based multipoint index map of human chromosome 22K H Buetow, D Duggan, B Yang, et al.
Pageof 7

Showing results (41-50 of 69) with videos related to

Sort By:
Pageof 7
Chest|May 1, 1979
Electrophysiologic study of the left ventricle: indications and safetyE L Michelson, S R Spielman, A M Greenspan, et al.
Circulation|March 1, 1979
Recurrent sustained ventricular tachycardia. 4. PleomorphismM E Josephson, L N Horowitz, A Farshidi, et al.
Clinical Pharmacology and Therapeutics|June 1, 1985
Conversion from intravenous to oral mexiletine in the acute management of repetitive ventricular arrhythmiaL N Horowitz, A M Greenspan, S R Spielman, et al.
Journal of the American College of Cardiology|July 1, 1987
Reduction in sudden death and total mortality by antiarrhythmic therapy evaluated by electrophysiologic drug testing: criteria of efficacy in patients with sustained ventricular tachyarrhythmiaT J Waller, H R Kay, S R Spielman, et al.
The American Journal of Cardiology|May 1, 1988
Relation of acute antiarrhythmic drug efficacy to left ventricular function in coronary artery diseaseM D Meissner, H R Kay, L N Horowitz, et al.
Journal of the American College of Cardiology|August 1, 1985
Limitations of failure of procainamide during electrophysiologic testing to predict response to other medical therapyA P Rae, N M Sokoloff, C R Webb, et al.
Archives of Internal Medicine|October 1, 1982
Intravenous nitroglycerin for rest angina. Potential pathophysiologic mechanisms of actionN L DePace, I M Herling, M N Kotler, et al.
The American Journal of Cardiology|August 1, 1985
Efficacy of combination therapy with mexiletine and a type IA agent for inducible ventricular tachyarrhythmias secondary to coronary artery diseaseA M Greenspan, S R Spielman, C R Webb, et al.
The American Journal of Cardiology|August 1, 1987
Determinants of hospital cost and length of stay for patients undergoing electrophysiologic testingH R Kay, L N Horowitz, H Goldstein, et al.
Genomics|November 1, 1993
A microsatellite-based multipoint index map of human chromosome 22K H Buetow, D Duggan, B Yang, et al.
Pageof 7